Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
Completed · Phase 1 · Has a placebo group
Conditions studied: Prostate Cancer
In brief
RATIONALE: The use of nutritional supplements, such as selenium, may stop prostate cancer from growing. Internal radiation, such as brachytherapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving selenium before brachytherapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase I trial is studying selenium to see how well it works compared to placebo in treating patients who are undergoing brachytherapy for stage I or stage II prostate cancer.
Key facts
- Study ID
- NCT00217516
- Run by
- Roswell Park Cancer Institute
- People needed
- 18
- Starts
- 2005-03-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2012-02-09
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.